ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.
ParcelBio has raised $13.2M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
ParcelBio's investors include General Catalyst, Alumni Ventures, Y Combinator, Pioneer Fund, ZAKA VC.
ParcelBio is headquartered in San Francisco, United States.
ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.
ParcelBio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ParcelBio — Funding & Investors." VCBacked, May 7, 2026, https://www.vcbacked.co/company/parcelbio. Accessed October 6, 2026.
VCBacked. (2026). ParcelBio — Funding & Investors. Retrieved October 6, 2026, from https://www.vcbacked.co/company/parcelbio
{{cite web |title=ParcelBio — Funding & Investors |url=https://www.vcbacked.co/company/parcelbio |website=VCBacked |access-date=October 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated